Top-Analysts PicksInvest alongside the top 15% of Wall Street analysts.

Try Top-Picks
Charles River Laboratories International, Inc. Financials Banner

Charles River Laboratories International, Inc. Financials

CRL Stock Analysis

Page title

Section title

CRL Income Statement Key Metrics

  • Revenue(TTM)4.08 B
  • Gross Profit(TTM)1.38 B
  • EBITDA(TTM)1.03 B
  • Net Income(TTM)431.79 M
  • EPS Diluted(TTM)8.459999999999999

Decode CRL's Latest Earnings Call with Ease

Tap 'Generate' for a crystal-clear,
AI-crafted summary and stay ahead in the investment game!

CRL earnings and revenue history

Gross Profit Margin vs Peers

Profit margin ratio of CRL (0.364) is lower than the average of its peers (0.465).

Net Profit Margin vs Peers

Net profit margin ratio of CRL (0.115) is higher than the average of its peers (-0.044).

CRL Return on Equity

See how efficiently CRL generates profit for it's shareholders.

13.20%

10
0
100
  1. Poor

  2. Average

  3. Strong

Return on Equity vs Peers

Return on Equity ratio of CRL (0.132) is higher than the average of its peers (-0.584).

Return on Equity Growth

CRL's Return on Equity has shown poor growth over the past 10 years, increasing by only -3.50%.

CRL Revenue Growth

See how CRL has grown it's revenue over the past 10 years.


Revenue Growth

CRL's revenue has grown significantly over the past 10 years, increasing by over 12.27%.

CRL FY, 2023 Revenue Breakdown

See how CRL converts it's revenue into profit.

CRL Balance Sheet Health

CRL Balance Sheet Breakdown 2023

Assets

  1. Long Term Assets

  2. Cash & Equivalents

  3. Inventory

  4. Receivables

  5. Property Plant Equipments

  6. Others

Liabilities

  1. Short Term Debt

  2. Long Term Debt

  3. Account Payables

  4. Others

CRL financial position analysis

Short Term Liabilities

CRL's short term assets($2B) can safely cover it's short term liabilities($1B).

Long Term Liabilities

CRL's short term assets($2B) cannot safely cover it's long term liabilities($3B).

CRL Debt to Equity